BACKGROUND: The glycoprotein YKL‐40 is synthesized both by cancer cells and by tumor‐
associated macrophages and plays a functional role in tumor progression. Consequently …

YKL‐40 is a glycoprotein secreted by macrophages, neutrophils and malignant tumor cells.
Elevated serum levels of YKL‐40 are associated with poor prognosis in several …

BACKGROUND YKL‐40 is a growth factor for connective tissue cells and stimulates
migration of endothelial cells. Cancer cells, macrophages, and neutrophils secrete YKL‐40 …

This study was to explore the association between the serum YKL-40 level and the clinical
characteristics, the response to chemotherapy and prognosis in small cell lung cancer …

YKL-40, a growth factor for connective tissue cells, is secreted by cancer cells and
macrophages. Elevated serum YKL-40 in patients with metastatic carcinoma has been …

Despite recent advances in the field of medical oncology, patients with advanced non-small
cell lung cancer (NSCLC) have a disappointing long-term prognosis. Accurate prognostic …

BACKGROUND YKL‐40 is a member of family 18 glycosyl hydrolases. YKL‐40 is a growth
factor and may stimulate migration of endothelial cells. YKL‐40 may also play a role in …

Purpose: YKL-40 is secreted by cancer cells, macrophages, and neutrophils. It may be a
growth or differentiation factor, play a role in angiogenesis, or protect against apoptosis …

Purpose To evaluate the novel tumor biomarker YKL-40 in serial serum samples from
patients with American Joint Committee on Cancer (AJCC) stage I and II melanoma from the …

YKL-40, a 40-kDa secreted glycoprotein, with its gene located on chromosome 1q32. 1, is
produced by cancer cells and inflammatory cells and has a role in inflammation, cell …